Imaging-based biomarkers predict PD-L1 and survival outcomes in advanced NSCLC treated with Nivolumab and Pembrolizumab: A multi-institutional study

Sevinj Yolchuyeva, Elena Giacomazzi,Marion Tonneau, Fabien Lamaze, Michèle Orain, Clément François,Julie Malo, Wiam Belkaïd,Bertrand Routy,Philippe Joubert,Venkata SK. Manem

JTO Clinical and Research Reports(2023)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要